Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483951 · ClinicalTrials.gov registry record
Cardiovascular Disease Screening
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Terminated
- Registry status
- 1,325
- Enrollment target
NCT00483951 is a clinical trial that was terminated before completion, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 1,325 participants.
The verdict
NCT00483951 was terminated before completion, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- TERMINATED
- Registry status
- 1,325 participants
- Enrollment target
Study Summary
This study will evaluate volunteers 18 years of age and older to see if they qualify for one of NHLBI s research studies. Tests include the following: * General medical evaluation, which may include blood tests, chest x-ray, electrocardiogram (ECG) and echocardiogram (heart ultrasound). * Other tests as appropriate, such as magnetic resonance imaging (MRI), cardiac computed tomography (CT scan of the heart), nuclear stress test and echocardiography stress test. * X-ray contrast studies of the heart and blood vessels. (These may be excluded in patients with kidney risk factors.)
Interventions
- DEVICE Toshiba Aquilion ONE CT
- DEVICE SWiemens MRI scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,325 participants |
| Start Date | 2008-01-28 |
| Est. Completion | 2020-11-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483951
The ClinicalTrials.gov registry entry for NCT00483951 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Toshiba Aquilion ONE CT is the first listed.
NCT00483951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483951 about?
NCT00483951 is a clinical study titled "Cardiovascular Disease Screening". This study will evaluate volunteers 18 years of age and older to see if they qualify for one of NHLBI s research studies. Tests include the following: * General medical evaluation, which may include blood tests, chest x-ray, electrocardiogram (ECG) and echocardiogram (heart ultrasound). * Other tes...
What is the current status of trial NCT00483951?
This trial is currently terminated. The enrollment target is 1,325 participants. The study started on 2008-01-28. Estimated completion is 2020-11-03.
What interventions are being tested in trial NCT00483951?
The interventions under investigation include: Toshiba Aquilion ONE CT (DEVICE), SWiemens MRI scanner (DEVICE).
Who is sponsoring clinical trial NCT00483951?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.